about
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral TherapyMortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study.Analysis of trends in adolescent suicides and accidental deaths in England and Wales, 1972-2011.Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs.CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).Trends in Pediatric Laboratory-Diagnosed Onychomycosis Between 2006 and 2014 in the Southwest of England.Evaluation of an intervention to reduce tidal volumes in ventilated ICU patients.Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination.Importance and Contribution of Community, Social, and Healthcare Risk Factors for Hepatitis C Infection in Pakistan.Methodological and statistical issues related to analysis of survival - Authors' reply.Cardiac magnetic resonance imaging provides new insight into hypertensive heart disease-a reply.Trends in laboratory-diagnosed onychomycosis between 2006 and 2014 in the South West of England.The Relationship Between Left Ventricular Wall Thickness, Myocardial Shortening, and Ejection Fraction in Hypertensive Heart Disease: Insights From Cardiac Magnetic Resonance Imaging.Optimising the imaging plane for right ventricular magnetic resonance volume analysis in adult patients referred for assessment of right ventricular structure and function.Usage of low dead space syringes and association with hepatitis C prevalence amongst people who inject drugs in the UKThe burden of hepatitis C virus infection in Punjab, India: A population-based serosurveyThe TeaM (Therapeutic Mammaplasty) study: Protocol for a prospective multi-centre cohort study to evaluate the practice and outcomes of therapeutic mammaplastyIncarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysisGlobal, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugsA global meta-analysis on HIV, hepatitis C and hepatitis B among people who inject drugs – do gender differences vary by country-level indicators?Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral TherapyScreening Strategies for Hepatitis C VirusFrom risk to care: the hepatitis C screening and diagnostic cascade in a primary health care clinic in Karachi, Pakistan—a cohort studyThe contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling studyCause-specific mortality after diagnosis of cancer among HIV-positive patients: A collaborative analysis of cohort studiesSocio-demographic and ecological factors associated with anti-HCV prevalence in people who inject drugs: A systematic reviewEffects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysisClustering of hepatitis C virus antibody positivity within households and communities in Punjab, IndiaPrevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta-analysisParameter estimates for trends and patterns of excess mortality among persons on ART in high-income european settingsAssociations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysisFrequency of injecting among people who inject drugs: A systematic review and meta-analysisThe prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysisModelling the potential prevention benefits of a treat-all hepatitis C treatment strategy at global, regional and country levels: A modelling studyPopulation network structures, graph theory, algorithms to match subgraphs may lead to better clustering of households and communities in epidemiological studies: a responseThe impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 studyGlobal systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalenceHepatitis C virus elimination in Indonesia: Epidemiological, cost and cost-effectiveness modelling to advance advocacy and strategic planning
P50
Q28391248-EBB4155E-87C2-4BBA-842A-72C033D65D12Q28553516-C5570E9F-7955-4638-A24C-6FA082CD4305Q36948126-D681CCC0-349F-4749-8598-A61C07E035B2Q37304197-6DB9C71E-E3E6-4841-AE50-EBB49FFDE3ACQ38890302-561BD436-4263-4FE0-AC3F-650CFF77A213Q40043083-DA34280B-2341-43FB-B274-B9437986EBDEQ40532239-1F9D4040-DCD1-4269-B642-C85FE2C0701EQ40934799-84D554EA-7B52-420E-B7B1-3F8EA4CCA770Q42699381-0A38103E-0CE9-47A3-AAE2-811016747EF8Q47197986-C23F48CD-2844-4D5A-A6F4-55884BF3FC3AQ47579352-306505B2-4C39-4F7F-A960-FCE3953B1907Q47764295-908F50A4-9E77-4F1B-8A70-0C69E3375812Q48005677-8E30A057-FFBE-4FCB-9639-5E6873138412Q48203813-CE8591FC-1149-46FE-93AF-E2990A3CF206Q48663527-036D37F4-B370-4072-8317-984551A9BC1DQ51031353-ADC4BC95-C244-4F97-91DB-7893C9040997Q57910003-622D7A8E-4619-4C26-9A3D-B70F9A9135ACQ58441411-F3621E49-7733-4819-B89C-0EB07842362BQ58441437-D1FD1434-ED43-4B5C-B6CC-D2C0653C24DCQ58598733-2CAA6AEA-2618-44B6-8E5F-F53BBA8BE70DQ60404232-E0ABC30F-3D4E-41DD-88CB-AFD45EAD04B1Q61953233-B0B2F380-E043-4511-903C-3E84B3DD18F7Q63683189-3497F523-B5A1-43B3-92D5-5FB79844B0C9Q63683192-4643DA02-161C-405F-8C16-1A7F62838DC5Q63683196-0580FEED-6812-49DA-ABBE-CD6875096792Q63684425-4CFDA879-3BE3-496F-81BA-E29D75155AFDQ89463361-C1E7B14B-F060-4861-892B-E2D4771EFD60Q89837221-89F95489-1E74-4A5F-9253-741A243C5B0EQ89840944-A5AD325C-1C7D-415F-BEE8-2C36234B7934Q90522230-FB44C8E4-97E1-491B-B90F-35E493132207Q90656523-FAB02BB6-968A-4B2F-8EFA-D5FC9919ECB2Q91434004-5DA15201-C4B0-4486-9EF7-F5197C997BA1Q91989084-F536F4EA-D768-43CE-84AB-8DAC82051724Q92170619-BB9CF8EA-B749-4396-B68F-97778CE2C3FDQ92222974-C02E6A0C-3E34-4699-B591-C0C00587A20CQ92491797-8744526E-8ABC-444E-A525-B917B6BAB1B5Q92523871-A48A50F0-8677-45A0-BDEF-0D5467BB8A7FQ92688448-DB15AAE5-0D98-4EEA-BAA2-E4E3C92152E3Q92731588-D5046BDF-0664-4239-BF7C-792471E1D32AQ92902211-CE003F7A-091A-45CB-A534-73033A6C52AB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Adam Trickey
@ast
Adam Trickey
@en
Adam Trickey
@es
Adam Trickey
@nl
type
label
Adam Trickey
@ast
Adam Trickey
@en
Adam Trickey
@es
Adam Trickey
@nl
prefLabel
Adam Trickey
@ast
Adam Trickey
@en
Adam Trickey
@es
Adam Trickey
@nl
P106
P1153
56600495600
P21
P31
P496
0000-0003-3462-2898